Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Schellens

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Topoisomerase I inhibition: a new target or new missiles?J Verweij, J H Schellens
Trends in Pharmacological Sciences|June 1, 1990
A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humansD D Breimer, J H Schellens
Pharmaceutisch Weekblad. Scientific Edition|April 24, 1987
Variability in drug metabolism: importance of genetic constitutionJ H Schellens, D D Breimer
Drugs|January 1, 1996
Emerging drug treatments for solid tumoursJ H Schellens, L C Pronk, J Verweij
Drug Safety|March 1, 1995
Antineoplastic agents. Drug interactions of clinical significanceE van Meerten, J Verweij, J H Schellens
Pharmacology & Therapeutics|January 1, 1989
Nifedipine: variability in its kinetics and metabolism in manD D Breimer, J H Schellens, P A Soons
Investigational New Drugs|June 8, 2001
Oral delivery of taxanesM M Malingré, J H Beijnen, J H Schellens
Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrationsJ Ma, G Stoter, J Verweij, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
BleomycinJ S Lazo, S M Sebti, J H Schellens
Biochemical Pharmacology|July 1, 1988
Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjectsJ H Schellens, P A Soons, D D Breimer
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Topoisomerase I inhibition: a new target or new missiles?J Verweij, J H Schellens
Trends in Pharmacological Sciences|June 1, 1990
A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humansD D Breimer, J H Schellens
Pharmaceutisch Weekblad. Scientific Edition|April 24, 1987
Variability in drug metabolism: importance of genetic constitutionJ H Schellens, D D Breimer
Drugs|January 1, 1996
Emerging drug treatments for solid tumoursJ H Schellens, L C Pronk, J Verweij
Drug Safety|March 1, 1995
Antineoplastic agents. Drug interactions of clinical significanceE van Meerten, J Verweij, J H Schellens
Pharmacology & Therapeutics|January 1, 1989
Nifedipine: variability in its kinetics and metabolism in manD D Breimer, J H Schellens, P A Soons
Investigational New Drugs|June 8, 2001
Oral delivery of taxanesM M Malingré, J H Beijnen, J H Schellens
Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrationsJ Ma, G Stoter, J Verweij, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
BleomycinJ S Lazo, S M Sebti, J H Schellens
Biochemical Pharmacology|July 1, 1988
Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjectsJ H Schellens, P A Soons, D D Breimer
Pageof 14